Ovarian Cancer Clinical Trials

Showing 1141-1160 of 1,169 trials

CT-2106 for the Second Line Treatment of Ovarian Cancer

NCT00291837

The purpose of this sudy is to determine the response rate of CT-2106 in patients with advanced ovarian cancer who have failed one prior platinum and taxane based regimen.

Ovarian Cancer

CTI BioPharma40 participantsStarted Nov 2004

Lyon, France • Saint-Brieuc, France • Campobasso, Italy +4 more locations

TERMINATEDPhase 2

Study of XL999 in Patients With Previously Treated Ovarian Cancer

NCT00277290

This clinical trial is being conducted at multiple sites to evaluate the activity, safety, and tolerability of XL999 when given weekly to patients with ovarian cancer that has previously been treated with platinum-based chemotherapy. XL999 is a small molecule inhibitor of multiple kinases including VEGFR, PDGFR, FGFR, FLT-3, and Src, which are involved in tumor cell growth, formation of new blood vessels (angiogenesis), and metastasis.

Ovarian Cancer

Symphony Evolution, Inc.24 participantsStarted Jan 2006

Greenbrae, California, United States • Port Saint Lucie, Florida, United States • Chicago, Illinois, United States +6 more locations

CT-2106 for the Second Line Treatment of Ovarian Cancer

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Related Searches

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Genetic Studies in Breast Cancer

Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

Screening and Identification of Ovarian Cancers

Women Surviving Ovarian Cancer

The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies

Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Examining the Long-Term Risks of Oophorectomy

SU5416 and Carboplatin to Treat Ovarian Cancer

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Vinorelbine and XR9576 to Treat Cancer

Clinical Trial for Ovarian Cancer (OvaRex®)